Jynarque 45MG, 15 MG

Ended Awarded Last action

Contract number
36C24526N0783
Awardee
Awarding agency
Obligated
$20,378

Award facts

Contract value 100% obligated
$20,378.21 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Belle Isle, FL 32809, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 5 issued a BPA call to Otsuka America Pharmaceutical Inc. on July 30, 2026, for Jynarque (tolvaptan) 45 mg and 15 mg tablets with a ceiling value of $20,378.21 and an ultimate completion date of August 4, 2026.

The call is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Belle Isle, Florida. The procurement is on a firm fixed price basis.

Quick answers

Who was awarded contract 36C24526N0783?

36C24526N0783 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 30, 2026.

How much is contract 36C24526N0783 worth?

The government has obligated $20,378 on 36C24526N0783.

Is contract 36C24526N0783 an order under another contract?

Yes. 36C24526N0783 is a BPA call under 36F79720D0099-36E79725A0011, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24526N0783 competed?

The extent of competition for 36C24526N0783 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award